Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects

Key concepts of the Nanoparticle-Allostatic Cross-Adaptation-Sensitization (NPCAS) Model for the action of homeopathic remedies in living systems include source nanoparticles as low level environmental stressors, heterotypic hormesis, cross-adaptation, allostasis (stress response network), time-dependent sensitization with endogenous amplification and bidirectional change, and self-organizing complex adaptive systems.

The model accommodates the requirement for measurable physical agents in the remedy (source nanoparticles and/or source adsorbed to silica nanoparticles). Hormetic adaptive responses in the organism, triggered by nanoparticles; bipolar, metaplastic change, dependent on the history of the organism. Clinical matching of the patient's symptom picture, including modalities, to the symptom pattern that the source material can cause (cross-adaptation and cross-sensitization). Evidence for nanoparticle-related quantum macro-entanglement in homeopathic pathogenetic trials.

This paper examines research implications of the model, discussing the following hypotheses: Variability in nanoparticle size, morphology, and aggregation affects remedy properties and reproducibility of findings. Homeopathic remedies modulate adaptive allostatic responses, with multiple dynamic short- and long-term effects. Simillimum remedy nanoparticles, as novel mild stressors corresponding to the organism's dysfunction initiate time-dependent cross-sensitization, reversing the direction of dysfunctional reactivity to environmental stressors.

The NPCAS model suggests a way forward for systematic research on homeopathy. The central proposition is that homeopathic treatment is a form of nanomedicine acting by modulation of endogenous adaptation and metaplastic amplification processes in the organism to enhance long-term systemic resilience and health.

Keywords

Nanoparticle - Homeopathy - Allostasis - Time-dependent sensitization - Metaplasticity - Cross-sensitization - Research design - Complex adaptive systems - Physiological stress response

• References

• 1 Bell I.R., Koithan M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complem Altern Med 2012; 12 (01) 191.
• 2 Pincus D., Metten A. Nonlinear dynamics in biopsychosocial resilience. Nonlinear Dynam Psychol Life Sci 2010; 14 (04) 353-380.
• 3 Danese A., McEwen B.S. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav Apr 12 2012; 106 (01) 29-39.
• 4 Karatsoreos I.N., McEwen B.S. Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci Dec 2011; 15 (12) 576-584.
• 5 Poston L. Intergenerational transmission of insulin resistance and type 2 diabetes. Prog Biophys Mol Biol Jul 2011; 106 (01) 315-322.
• 6 Crews D., Gillette R., Scarpino S.V., Manikkam M., Savenkova M.I., Skinner M.K. Epigenetic transgenerational inheritance of altered stress responses. Proc Natl Acad Sci USA 2012; 109 (23) 9143-9148.
• 7 Bellavite P., Ortolani R., Pontarollo F., Pitari G., Conforti A. Immunology and homeopathy. 5. The rationale of the ‘Simile’. Evid Based Complement Alternat Med Jun 2007; 4 (02) 149-163.
• 8 Abraham W.C., Bear M.F. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci Apr 1996; 19 (04) 126-130.
• 9 Abraham W.C. Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci May 2008; 9 (05) 387.
• 10 Antelman S.M., Caggiula A.R. Oscillation follows drug sensitization: implications. Crit Rev Neurobiol 1996; 10 (01) 101-117.
• 11 Antelman S.M., Caggiula A.R., Edwards D.J. et al. Long-term oscillation of corticosterone following intermittent cocaine. J Neural Transm 2000; 107 (03) 369-375.
• 12 Antelman S.M., Caggiula A.R., Kocan D. et al. One experience with ‘lower’ or ‘higher’ intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res 1991; 566 (1–): 276-283.
• 13 Bell I.R., Schwartz G.E. Adaptive network nanomedicine: an integrated model for homeopathic medicine. Front Biosci (Scholar Ed.) 2013; 5 (02) 685-708.
• 14 Chikramane P.S., Suresh A.K., Bellare J.R., Kane S.G. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010; 99 (04) 231-242.
• 15 Ives J.A., Moffett J.R., Arun P. et al. Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy Jan 2010; 99 (01) 15-24.
• 16 Anick D.J., Ives J.A. The silica hypothesis for homeopathy: physical chemistry. Homeopathy 2007; 96 (03) 189-195.
• 17 Rao M., Roy R., Bell I.R. Characterization of the structure of ultra dilute sols with remarkable biological properties. Mater Lett 2008; 62: 1487-1490.
• 18 Rao M.L., Roy R., Bell I.R., Hoover R. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy Jul 2007; 96 (03) 175-182.
• 19 Upadhyay R.P., Nayak C. Homeopathy emerging as nanomedicine. Int J High Dilution Res 2011; 10 (37) 299-310.
• 20 Das S., Das J., Samadder A., Bhattacharyya S., Das D., Khuda-Bukhsh A.R. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces 2013; 101: 325-336.
• 21 Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev 2006; 35 (07) 583-592.
• 22 Buzea C., Pacheco II. Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007; 2 (04) MR17-MR71.
• 23 Kovacic P., Somanathan R. Biomechanisms of nanoparticles (toxicants, antioxidants and therapeutics): electron transfer and reactive oxygen species. J Nanosci Nanotechnol Dec 2010; 10 (12) 7919-7930.
• 24 Winnik F.M., Maysinger D. Quantum dot cytotoxicity and ways to reduce it. Acc Chem Res 2012 July 9 epub ahead of print.
• 25 Prakash D.J., Arulkumar S., Sabesan M. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stress induced behavioral and biochemical alteration in male albino mice. Pharmacognosy Res Nov 2010; 2 (06) 330-334.
• 26 Al-Sadoon M.K., Abdel-Maksoud M.A., Rabah D.M., Badr G. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between Bcl2 and Caspase 3. Cell Physiol Biochem 2012; 30 (03) 653-665.
• 27 Iavicoli I., Calabrese E.J., Nascarella M.A. Exposure to nanoparticles and hormesis. Dose Response 2010; 8 (04) 501-517.
• 28 McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol Apr 7 2008; 583 (2–): 174-185.
• 29 Barbieri M., Boccardi V., Papa M., Paolisso G. Metabolic journey to healthy longevity. Horm Res Jan 2009; 71 (Suppl. 01) 24-27.
• 30 Karst H., Berger S., Erdmann G., Schutz G., Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A Aug 10 2010; 107 (32) 14449-14454.
• 31 Delvendahl I., Jung N.H., Mainberger F., Kuhnke N.G., Cronjaeger M., Mall V. Occlusion of bidirectional plasticity by preceding low-frequency stimulation in the human motor cortex. Clin Neurophysiol Apr 2010; 121 (04) 594-602.
• 32 Wang S.Z., Tao H.W. History matters: illuminating metaplasticity in the developing brain. Neuron Oct 29 2009; 64 (02) 155-157.
• 33 Moussawi K., Pacchioni A., Moran M. et al. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci Feb 2009; 12 (02) 182-189.
• 34 Kalantzis G., Shouval H.Z. Structural plasticity can produce metaplasticity. PLoS ONE 2009; 4 (11) e8062.
• 35 Dudai Y. Predicting not to predict too much: how the cellular machinery of memory anticipates the uncertain future. Philos Trans R Soc Lond B Biol Sci May 12 2009; 364 (1521) 1255-1262.
• 36 Yu X., Shouval H.Z., Knierim J.J. A biophysical model of synaptic plasticity and metaplasticity can account for the dynamics of the backward shift of hippocampal place fields. J Neurophysiol Aug 2008; 100 (02) 983-992.
• 37 Stebbing A.R. Adaptive responses account for the beta-curve-hormesis is linked to acquired tolerance. Nonlinearity Biol Toxicol Med Oct 2003; 1 (04) 493-511.
• 38 Calabrese E.J., Jonas W.B. Homeopathy: clarifying its relationship to hormesis. Hum Exp Toxicol Jul 2010; 29 (07) 531-536.
• 39 Calabrese E.J., Jonas W.B. Evaluating homeopathic drugs within a biomedical framework. Hum Exp Toxicol Jul 2010; 29 (07) 545-549.
• 40 Ning X.H., Chen S.H. Mild hypothermic cross adaptation resists hypoxic injury in hearts: a brief review. Chin J Physiol Oct 31 2006; 49 (05) 213-222.
• 41 Hale H.B. Cross-adaptation. Environ Res 1969; 2: 423-434.
• 42 Adolph E.F. General and specific characteristics of physiological adaptations. Am J Physiol 1956; 184: 18-28.
• 43 Launay J.C., Besnard Y., Guinet-Lebreton A., Savourey G. Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level. Aviat Space Environ Med Dec 2006; 77 (12) 1230-1235.
• 44 Banti V., Loreti E., Novi G., Santaniello A., Alpi A., Perata P. Heat acclimation and cross-tolerance against anoxia in Arabidopsis. Plant Cell Environ Jul 2008; 31 (07) 1029-1037.
• 45 Lunt H.C., Barwood M.J., Corbett J., Tipton M.J. ‘Cross-adaptation’: habituation to short repeated cold-water immersions affects the response to acute hypoxia in humans. J Physiol Sep 15 2010; 588 (Pt 18): 3605-3613.
• 46 Ganta S., Devalapally H., Shahiwala A., Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release Mar 20 2008; 126 (03) 187-204.
• 47 Antelman S.M., Levine J., Gershon S. Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic.[comment]. Mol Psychiatry 2000; 5 (04) 350-356.
• 48 Pacheco K.A. Epigenetics mediate environment: gene effects on occupational sensitization. Curr Opin Allergy Clin Immunol Apr 2012; 12 (02) 111-118.
• 49 Hauger R.L., Olivares-Reyes J.A., Dautzenberg F.M., Lohr J.B., Braun S., Oakley R.H. Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy. Neuropharmacology Feb 2012; 62 (02) 705-714.
• 50 Seery M.D., Leo R.J., Holman E.A., Silver R.C. Lifetime exposure to adversity predicts functional impairment and healthcare utilization among individuals with chronic back pain. Pain Sep 2010; 150 (03) 507-515.
• 51 Nascarella M.A., Calabrese E.J. A method to evaluate hormesis in nanoparticle dose-responses. Dose Response 2012; 10 (03) 344-354.
• 52 Bell I.R., Howerter A., Jackson N., Brooks A.J., Schwartz G.E. Multi-week resting EEG cordance change patterns from repeated olfactory activation with two constitutionally-salient homeopathic remedies in healthy young adults. J Altern Complement Med 2012; 18 (05) 445-453.
• 53 Bell I.R., Howerter A., Jackson N., Aickin M., Baldwin C.M., Bootzin R.R. Effects of homeopathic medicines on polysomnographic sleep of young adults with histories of coffee-related insomnia. Sleep Med May 2011; 12 (05) 505-511.
• 54 Mishra N., Muraleedharan K.C., Paranjpe A.S., Munta D.K., Singh H., Nayak C. An exploratory study on scientific investigations in homeopathy using medical analyzer. J Altern Complement Med Aug 2011; 17 (08) 705-710.
• 55 Van Wijk R., Wiegant F.A. Postconditioning hormesis and the similia principle. Front Biosci (Elite Ed.) 2011; 3: 1128-1138.
• 56 Wiegant F., Van Wijk R. The similia principle: results obtained in a cellular model system. Homeopathy Jan 2010; 99 (01) 3-14.
• 57 Van Wijk R., Wiegant F.A. Postconditioning hormesis and the homeopathic Similia principle: molecular aspects. Hum Exp Toxicol Jul 2010; 29 (07) 561-565.
• 58 Sorg B., Bailie T., Tschirgi M., Li N., Wu W. Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Brain Res 2001; 898 (02) 314-320.
• 59 Frank M.G., Thompson B.M., Watkins L.R., Maier S.F. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun Feb 2012; 26 (02) 337-345.
• 60 Frank M.G., Watkins L.R., Maier S.F. Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav Immun Jan 21 2011; 25 (Suppl. 01) S21-S28.
• 61 Chourbaji S., Vogt M.A., Gass P. Mice that under- or overexpress glucocorticoid receptors as models for depression or posttraumatic stress disorder. Prog Brain Res 2008; 167: 65-77.
• 62 Mormede P., Andanson S., Auperin B. et al. Exploration of the hypothalamic-pituitary-adrenal function as a tool to evaluate animal welfare. Physiol Behav Oct 22 2007; 92 (03) 317-339.
• 63 Fee J.R., Sparta D.R., Picker M.J., Thiele T.E. Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice. Neuroscience Nov 30 2007; 150 (01) 14-21.
• 64 Chida Y., Sudo N., Sonoda J., Hiramoto T., Kubo C. Early-life psychological stress exacerbates adult mouse asthma via the hypothalamus-pituitary-adrenal axis. Am J Respir Crit Care Med Feb 15 2007; 175 (04) 316-322.
• 65 Prasad B.M., Ulibarri C., Sorg B.A. Stress-induced cross-sensitization to cocaine: effect of adrenalectomy and corticosterone after short- and long-term withdrawal. Psychopharmacology 1998; 136 (01) 24-33.
• 66 Roeska K., Seilheimer B. Antiviral activity of Engystol^® and Gripp-Heel^®: an in-vitro assessment. J Immune Based Ther Vaccines 2010; 8: 6.
• 67 Glatthaar-Saalmuller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Can J Physiol Pharmacol Nov 2007; 85 (11) 1084-1090.
• 68 Smit E., Oberholzer H.M., Pretorius E. A review of immunomodulators with reference to Canova. Homeopathy Jul 2009; 98 (03) 169-176.
• 69 Burbano R.R., Leal M.F., da Costa J.B. et al. Lymphocyte proliferation stimulated by activated human macrophages treated with Canova. Homeopathy Jan 2009; 98 (01) 45-48.
• 70 Aleixo D.L., Ferraz F.N., de Melo C.S. et al. Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole. Homeopathy Apr 2008; 97 (02) 59-64.
• 71 Vithoulkas G. The science of homeopathy. N.Y.: Grove Weidenfeld; 1980.
• 72 Wiegant F.A., Prins H.A., Van Wijk R. Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response 2011; 9 (02) 209-224.
• 73 Banerjee P., Biswas S.J., Belon P., Khuda-Bukhsh A.R. A potentized homeopathic drug, Arsenicum Album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice. J Vet Med A Physiol Pathol Clin Med Sep 2007; 54 (07) 370-376.
• 74 Bortolotto Z.A., Collett V.J., Conquet F., Jia Z., Collingridge G.L. An analysis of the stimulus requirements for setting the molecular switch reveals a lower threshold for metaplasticity than synaptic plasticity. Neuropharmacology Sep 2008; 55 (04) 454-458.
• 75 Wiegant F.A., Spieker N., van Wijk R. Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology May 15 1998; 127 (1–3): 107-119.
• 76 Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature Jan 19 2012; 481 (7381) 278-286.
• 77 Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun May 2010; 34 (03) J226-J233.
• 78 McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev Jul 2007; 87 (03) 873-904.
• 79 Dagenais M., Skeldon A., Saleh M. The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ Jan 2012; 19 (01) 5-12.
• 80 Vasquez A., Dobrin R., Sergi D., Eckmann J.P., Oltvai Z.N., Barabasi A.L. The topological relationship between the large-scale attributes and local interaction patterns of complex networks. Proc Natl Acad Sci U S A 2004; 101 (52) 17940-17945.
• 81 Platt J.R. Strong inference. Science 1964; 146 (3642) 347-353.
• 82 Baumgartner S. The state of basic research on homeopathy. In: Witt C., Albrecht H. (eds). New Directions in Homeopathy Research. 2009. Essen, Germany: KVC Verlag; 107-130.
• 83 Baumgartner S., Shah D., Schaller J., Kampfer U., Thurneysen A., Heusser P. Reproducibility of dwarf pea shoot growth stimulation by homeopathic potencies of gibberellic acid. Complement Ther Med Aug 2008; 16 (04) 183-191.
• 84 Belon P., Cumps J., Ennis M. et al. Histamine dilutions modulate basophil activation. Inflamm Res 2004; 53 (05) 181-188.
• 85 Cao G., Wang Y. Nanostructures and nanomaterials: synthesis, properties, and applications. 2nd edn. New Jersey: World Scientific; 2011.
• 86 Shi Z., Huang X., Liu B., Tao H., Cai Y., Tang R. Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite. J Biomater Appl Jul 2010; 25 (01) 19-37.
• 87 Napierska D., Thomassen L.C., Rabolli V. et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small Apr 2009; 5 (07) 846-853.
• 88 Keck C.M., Muller R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm Jan 2006; 62 (01) 3-16.
• 89 Merisko-Liversidge E., Liversidge G.G. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev May 30 2011; 63 (06) 427-440.
• 90 Perry C.C., Keeling-Tucker T. Aspects of the bioinorganic chemistry of silicon in conjunction with the biometals calcium, iron and aluminium. J Inorg Biochem Feb 15 1998; 69 (03) 181-191.
• 91 Perry C.C., Keeling-Tucker T. Model studies of colloidal silica precipitation using biosilica extracts from Equisetum telmateia . Colloid Polym Sci Jul 01 2003; 281 (07) 652-664.
• 92 Caron V., Willart J.F., Lefort R., Derollez P., Danede F., Descamps M. Solid state amorphization kinetic of alpha lactose upon mechanical milling. Carbohydr Res Nov 29 2011; 346 (16) 2622-2628.
• 93 Tavares Cardoso M.A., Talebi M., Soares P.A., Yurteri C.U., van Ommen J.R. Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying. Int J Pharm Jul 29 2011; 414 (1–2): 1-5.
• 94 Demangeat J.L. NMR relaxation evidence for solute-induced nanosized superstructures in ultramolecular aqueous dilutions of silica-lactose. J Mol Liquids 2010; 155: 71-79.
• 95 Bhattacharyya S.S., Das J., Das S. et al. Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture Phytolacca Decandra. Zhong Xi Yi Jie He Xue Bao May 2012; 10 (05) 546-554.
• 96 Bhattacharyya S.S., Mandal S.K., Biswas R. et al. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med (Maywood) Dec 2008; 233 (12) 1591-1601.
• 97 Ives J.A., Jonas W.B., Frye J.C. Do serial dilutions really dilute?. Homeopathy Oct 2010; 99 (04) 229-230.
• 98 Liu L., Randolph T.W., Carpenter J.F. Particles shed from syringe filters and their effects on agitation-induced protein aggregation. J Pharm Sci Aug 2012; 101 (08) 2952-2959.
• 99 Song L., Yang K., Jiang W., Du P., Xing B. Adsorption of bovine serum albumin on nano and bulk oxide particles in deionized water. Colloids Surf B Biointerfaces Jun 1 2012; 94: 341-346.